Jo Anne Valentino

Chief Operating Officer • Minaris Regenerative Medicine

Jo Anne Valentino is Chief Operating Officer of Minaris Regenerative Medicine, LLC (United States). She is an accomplished senior leader with over 20 years’ experience.

After joining the company in January 2019, Jo Anne served as Global Head of Quality for the Regenerative Medicine Business Sector of Showa Denko Materials Co., Ltd. and Vice President of Minaris (United States) (formerly named Hitachi Chemical Advanced Therapeutic Solutions). As Global Head of Quality with demonstrated success in challenging compliance environments, including transitions resulting from mergers and acquisitions, Jo Anne developed and led the implementation of the company’s integrated global quality strategy. She was appointed COO of our United States operations in October 2021. In this role, she is responsible for oversight of all US development and manufacturing operations. Jo Anne is responsible to oversee the transformation and growth of the operations organization, including commercialization, expansion, and infrastructure investment. She serves as a member of our global Management Strategic Council and will collaborate on a Global Functional Team to ensure alignment across the three regional companies.

For more than seven years, Jo Anne worked at Novartis in quality positions of increasing responsibility, including Executive Director, Quality Head, External Supply Operations, Americas region. In that role she ensured robust Quality oversight for a large portfolio of external suppliers and supported strategic initiatives in the region, product launches and transfers, business integrations, and global compliance improvement initiatives. Prior to Novartis, Jo Anne was in leadership positions at Merck and Schering-Plough in Operations and Quality, as well as product and process development at Reckitt Benckiser.

Jo Anne received her MS in management from Stevens Institute of Technology and her BS in chemical engineering from Manhattan College.

Also Speaking

Dr David DiGusto

Chief Technology Officer • Resilience

Robert Speziale

Peter Walters

Director, Advanced Therapies • CRB

Event Info


Fun Run